Exelixis (EXEL) Change in Receivables (2013 - 2026)

Exelixis' (EXEL) quarterly Change in Receivables came in at $42.0 million in Q2 2026, up 160.75% year-on-year from $16.1 million in Q2 2025, and up 284.27% quarter-over-quarter from -$22.8 million in Q1 2026.

Exelixis (EXEL) Change in Receivables (2013 - 2026) Analysis & Trends

Exelixis' Change in Receivables history runs 14 years deep, the most recent figure standing at $42.0 million for Q2 2026.

  • On a quarterly basis, Change in Receivables rose 160.75% year-over-year to $42.0 million in Q2 2026; TTM through Apr 2026 was $47.3 million, a 15.68% increase from a year earlier, with the FY2026 full-year figure at $21.4 million, down 23.44% from the prior year.
  • Change in Receivables grew to $42.0 million in Q2 2026 per EXEL's latest filing, from -$22.8 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $156.0 million in Q2 2024 and bottomed at -$127.0 million in Q3 2024.
  • The 5-year median for Change in Receivables is $3.2 million (2024), against an average of $2.8 million.
  • Across the five-year window, Change in Receivables tumbled 27370.73% in 2023 and soared 18223.93% in 2024, its largest moves.
  • Year by year, Change in Receivables stood at $41000.0 in 2022, then tumbled by 27370.73% to -$11.2 million in 2023, then sank by 1036.08% to -$127.0 million in 2024, then soared by 113.67% to $17.4 million in 2025, then jumped by 141.97% to $42.0 million in 2026.
  • Per Business Quant, the three latest EXEL Change in Receivables figures stand at $42.0 million (Q2 2026), -$22.8 million (Q1 2026), and $17.4 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 75.30 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -39.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -1.20 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Exelixis 14.44 Bn 13.66 Bn 590.86 Mn 42.03 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 42.03 Mn
Apr 3, 2026 42.03 Mn
Jan 2, 2026 -22.81 Mn
Jan 2, 2026 -22.81 Mn
Oct 3, 2025 17.37 Mn
Oct 3, 2025 17.37 Mn
Jul 4, 2025 10.72 Mn
Jul 4, 2025 10.72 Mn
Apr 4, 2025 16.12 Mn
Apr 4, 2025 16.12 Mn
Jan 3, 2025 -4.24 Mn
Jan 3, 2025 -4.24 Mn
Sep 27, 2024 -127.03 Mn
Sep 27, 2024 -127.03 Mn
Jun 28, 2024 156.05 Mn
Jun 28, 2024 156.05 Mn
Mar 29, 2024 3.17 Mn
Mar 29, 2024 3.17 Mn
Dec 29, 2023 -11.18 Mn
Dec 29, 2023 -11.18 Mn